---
title: Oxford Biomedica vs Porton Advanced
slug_a: oxb
slug_b: porton-advanced
site: cdmo
review_signal_gate: closed
canonical_path: /compare/oxb/porton-advanced
generated_by: BioBM Editorial AI
---

# Oxford Biomedica vs Porton Advanced

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Oxford Biomedica (oxb) is listed for cdmo. Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.

Services: 12. Modalities: 4. Indications: 3. Locations: 17. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (17).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Porton Advanced (porton-advanced) is listed for cdmo. End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe.

Services: 14. Modalities: 4. Indications: 0. Locations: 18. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (18).

Review summary: Review summary withheld until site-level review gate opens.